Financhill
Sell
27

DSRLF Quote, Financials, Valuation and Earnings

Last price:
$69.4900
Seasonality move :
66668.84%
Day range:
$69.4900 - $69.4900
52-week range:
$66.5000 - $112.3000
Dividend yield:
1.93%
P/E ratio:
18.52x
P/S ratio:
2.92x
P/B ratio:
5.36x
Volume:
--
Avg. volume:
486
1-year change:
-36.12%
Market cap:
$3.7B
Revenue:
$1.3B
EPS (TTM):
$3.77

Analysts' Opinion

  • Consensus Rating
    No consensus rating exists at this time due to lack of analyst coverage.
  • Price Target Downside
    No price target exists because of limited analyst coverage.
  • Price Target Upside
    Similarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.

Fair Value

  • According to the consensus of 0 analysts, DiaSorin SpA has -- downside to fair value with a price target of -- per share.

DSRLF vs. S&P 500

  • Over the past 5 trading days, DiaSorin SpA has overperformed the S&P 500 by 0.17% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • DiaSorin SpA does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • DiaSorin SpA has grown year-over-year revenues for 5 quarters straight. In the most recent quarter DiaSorin SpA reported revenues of $347.3M.

Earnings Growth

  • DiaSorin SpA has grown year-over-year earnings for 6 quarters straight. In the most recent quarter DiaSorin SpA reported earnings per share of $1.00.
Enterprise value:
3.6B
EV / Invested capital:
--
Price / LTM sales:
2.92x
EV / EBIT:
11.17x
EV / Revenue:
2.75x
PEG ratio (5yr expected):
1.27x
EV / Free cash flow:
14.49x
Price / Operating cash flow:
15.36x
Enterprise value / EBITDA:
7.79x
Gross Profit (TTM):
$804.7M
Return On Assets:
6.21%
Net Income Margin (TTM):
15.66%
Return On Equity:
11.91%
Return On Invested Capital:
9.23%
Operating Margin:
24.59%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-06-30 2024-06-30 2025-06-30 2024-06-30 2025-06-30
Income Statement
Revenue $1.3B $1.3B $1.3B $323.2M $347.3M
Gross Profit $809.9M $754M $804.7M $213.1M $229M
Operating Income $321.6M $266.9M $325.9M $76.3M $85.4M
EBITDA $463.4M $414.5M $467.1M $80.3M $79.6M
Diluted EPS $3.28 $3.27 $3.75 $1.01 $1.00
Period Ending 2021-06-30 2022-06-30 2023-06-30 2024-06-30 2025-06-30
Balance Sheet
Current Assets -- $1B -- $890.6M $890.8M
Total Assets -- $3.6B $2.5B $3.4B $3.4B
Current Liabilities -- $244.1M -- $285.5M $651.3M
Total Liabilities -- $2B $827.4M $1.6B $1.6B
Total Equity $1.4B $1.6B $1.6B $1.7B $1.8B
Total Debt -- -- -- -- --
Trailing 12 Months Fiscal Quarters
Period Ending 2023-06-30 2024-06-30 2025-06-30 2024-06-30 2025-06-30
Cash Flow Statement
Cash Flow Operations $369.4M $347M $379.3M $85.3M $89.7M
Cash From Investing -$66M -$159.9M -$72.4M -$54.2M -$39.9M
Cash From Financing -$413.7M -$283M -$292.1M -$186.2M -$243.5M
Free Cash Flow $259.5M $205.1M $251.2M $15.1M $18.1M
DSRLF
Sector
Market Cap
$3.7B
$28.6M
Price % of 52-Week High
61.88%
51.66%
Dividend Yield
1.93%
0%
Shareholder Yield
0.39%
-1.34%
1-Year Price Total Return
-36.12%
-20.19%
Beta (5-Year)
-7,389.134
0.519
Dividend yield:
1.93%
Annualized payout:
$1.25
Payout ratio:
-33.23%
Growth streak:
2 years

Technicals

8-day SMA
Buy
Level $69.1700
200-day SMA
Sell
Level $99.7167
Bollinger Bands (100)
Sell
Level 77.8943 - 105.4143
Chaikin Money Flow
Sell
Level -341
20-day SMA
Buy
Level $69.3585
Relative Strength Index (RSI14)
Sell
Level 31.3832
ADX Line
Sell
Level 61.5011
Williams %R
Sell
Level -15.5367
50-day SMA
Sell
Level $81.6930
MACD (12, 26)
Sell
Level -3.3292
25-day Aroon Oscillator
Sell
Level -44
On Balance Volume
Neutral
Level 114.2K

Financial Scores

Buy
Altman Z-Score (Annual)
Level (3.8005)
Buy
CA Score (Annual)
Level (0.1198)
--
Beneish M-Score (Annual)
Level (--)
Buy
Momentum Score
Level (4)
Buy
Ohlson Score
Level (-1.0723)
Buy
Piotroski F Score (Annual)
Level (9)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (6)

Revenue Forecast

Earnings per Share Forecast

Company Profile

DiaSorin SpA engages in developing, producing and marketing reagent kits for laboratory diagnostics. It operates through following segments Immunodiagnostics, Molecular Diagnostics, and Life Science. The Immunodiagnostics segment engages in the development of new tests based on complex algorithms. The Molecular Diagnostics segment focuses on providing specialty tests and complex multiplex solutions. The Life Science segment offers diagnostic instruments and technology. The firm provides clinical services in areas like Infectious diseases, bone and mineral, endocrinology, hypertension, oncology, stool diagnostics and autoimmunity. The company was founded in 1968 and is headquartered in Saluggia, Italy.

Stock Forecast FAQ

In the current month, DSRLF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The DSRLF average analyst price target in the past 3 months is --.

  • Where Will DiaSorin SpA Stock Be In 1 Year?

    According to analysts, the consensus estimate is that DiaSorin SpA share price will drop to -- per share over the next 12 months.

  • What Do Analysts Say About DiaSorin SpA?

    Analysts are divided on their view about DiaSorin SpA share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that DiaSorin SpA is a Sell and believe this share price will rise from its current level to --.

  • What Is DiaSorin SpA's Price Target?

    The price target for DiaSorin SpA over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is DSRLF A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for DiaSorin SpA is a --. 0 of 0 analysts rate the stock a -- at this time.

  • How Can I Buy Shares Of DSRLF?

    You can purchase shares of DiaSorin SpA via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase DiaSorin SpA shares.

  • What Is The DiaSorin SpA Share Price Today?

    DiaSorin SpA was last trading at $69.4900 per share. This represents the most recent stock quote for DiaSorin SpA. Yesterday, DiaSorin SpA closed at $69.4900 per share.

  • How To Buy DiaSorin SpA Stock Online?

    In order to purchase DiaSorin SpA stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is JetBlue The Best Airline Stock?
Is JetBlue The Best Airline Stock?

Following a general trend of improvement among airline stocks, shares…

Why Did Netflix Buy Warner Bros?
Why Did Netflix Buy Warner Bros?

Following a bidding war, Netflix (NASDAQ:NFLX) has announced its intention…

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Stock Ideas

Buy
51
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
58
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
59
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
54
SMX alert for Dec 12

SMX (Security Matters) Plc [SMX] is down 8.52% over the past day.

Buy
77
DHIL alert for Dec 12

Diamond Hill Investment Group, Inc. [DHIL] is up 0.04% over the past day.

Sell
28
OXM alert for Dec 12

Oxford Industries, Inc. [OXM] is up 10.73% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock